Condensed Consolidated Balance Sheets - USD ($) $ in Thousands	Jun. 30, 2015	Dec. 31, 2014
Current assets:
Cash and cash equivalents ($9,883 and $7,202 related to VIEs)	$ 62,082	$ 99,167
Restricted cash	3,050	7,051
Accounts receivable, net ($19,858 and $13,799 related to VIEs)	163,117	137,807
Prepaid expenses ($1,028 and $651 related to VIEs)	11,792	8,728
Inventories ($318 and $370 related to VIEs)	4,414	4,526
Deferred income taxes ($6 and $6 related to VIEs)	146	227
Other ($370 and $403 related to VIEs)	8,506	7,457
Total current assets	253,107	264,963
Equity investments in joint ventures	1,251	1,646
Property and equipment, net ($23,281 and $19,051 related to VIEs)	260,065	270,757
Real estate subject to finance obligation	11,556	22,552
Goodwill ($78,665 and $54,377 related to VIEs)	492,724	469,596
Intangible assets, net ($14,024 and $12,421 related to VIEs)	77,830	81,680
Other assets ($6,309 and $6,335 related to VIEs)	50,498	35,530
Total assets	1,147,031	1,146,724
Current liabilities:
Accounts payable ($2,378 and $1,270 related to VIEs)	60,161	57,635
Accrued expenses ($3,408 and $3,534 related to VIEs)	101,108	82,609
Income taxes payable ($0 and $0 related to VIEs)	3,621	2,114
Current portion of long-term debt ($76 and $14 related to VIEs)	30,890	26,350
Current portion of finance obligation	277	433
Other current liabilities	8,739	19,687
Total current liabilities	204,796	188,828
Long-term debt, less current portion ($197 and $11 related to VIEs)	999,679	940,771
Finance obligation, less current portion	12,197	23,610
Embedded derivative features of Series A convertible redeemable preferred stock	22,402	15,843
Other long-term liabilities ($2,769 and $2,474 related to VIEs)	44,694	51,079
Deferred income taxes	3,598	4,480
Total liabilities	1,287,366	1,224,611
Series A convertible redeemable preferred stock, $0.001 par value, $1,000 stated value, 3,500,000 authorized, 385,000 issued and outstanding at June 30, 2015 and December 31, 2014	378,471	328,926
Noncontrolling interests - redeemable	$ 68,794	$ 49,797
Commitments and contingencies
Equity:
Common stock, $0.01 par value, 1,000,000 shares authorized, 1,028 issued and outstanding at June 30, 2015 and December 31, 2014
Additional paid-in capital	$ 576,083	$ 626,001
Retained deficit	(1,147,267)	(1,067,487)
Accumulated other comprehensive loss, net of tax	(42,735)	(38,690)
Total 21st Century Oncology Holdings, Inc. shareholder's deficit	(613,919)	(480,176)
Noncontrolling interests - nonredeemable	26,319	23,566
Total deficit	(587,600)	(456,610)
Total liabilities and equity	$ 1,147,031	$ 1,146,724